Naloxone Hydrochloride
Product Images NDC 63629-9321

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 63629-9321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (a) (2y2 Figure 1 (a))

This is a table showing the different concentrations of Naloxone (in ng/mL) that can be achieved through different methods of administration such as nasal spray and intramuscular injection over time (in hours) post-dose. The table includes dosages for one or both nostrils and indicates the concentration of Naloxone in each case (20 mg/mL or 40 mg/mL). A dosage of 0 is also mentioned without any indication of administration.*

FDA Label Image

Figure 1 (b) (2y2 Figure 1 (b))

This document provides instructions for administering Naloxone, a medication that can restore normal breathing in an individual who has stopped breathing due to an opioid overdose. The chart gives recommended doses based on the required plasma concentration, with variations depending on the specific spray or injection used. Additionally, there is a time frame included for monitoring the patient after the initial dose.*

FDA Label Image

Step 3 (2y2 Step 3)

FDA Label Image

Step 4 (2y2 Step 4)

FDA Label Image

Step 5 (2y2 Step 5)

FDA Label Image

Step 7 (2y2 Step 7)

FDA Label Image

Chemical Structure (Chemical Structure)

FDA Label Image

Step 2 (Image 01)

FDA Label Image

Step1-image1 (Image 02)

FDA Label Image

Label (Lbl636299321)

This is a description of Naloxone HCI Nasal Spray, which is used for known or suspected opioid overdose in adults and children. The medication should be stored at or below 77°F (25°C) and protected from light. Each nasal spray contains 4 mg of Naloxone Hydrochloride and should not be removed or tested until ready for use. The spray comes in a two-pack of single doses and should be kept out of children's reach.*

FDA Label Image

Step 1 (Quick Start Guide Step 1)

FDA Label Image

Step 2 Image 2 (Quick Start Guide Step 2 Image 2)

This is a list of two words, "Nozzle" and "Plunger". It is not possible to provide a useful description with such limited information.*

FDA Label Image

Step 3 (Quick Start Guide Step 3)

This is a simple diagram or pictogram that demonstrates how to support the head using the hand and prevent the body from rolling onto the stomach by stopping the knee.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.